Robyn Broad

Robyn Broad is a principal scientist at Adaptimmune, with extensive experience in tumour profiling and translational sciences. Prior to their current role, Robyn worked as a scientist in target validation and as an industrial placement student at MedImmune. Robyn holds a Doctor of Philosophy degree in Molecular Medicine from the University of Leeds, and has a strong background in cancer research and biochemistry. Robyn is skilled in a variety of techniques including chromogen staining, qPCR, image analysis, and plasmid transformations. Their work involves the analysis of clinical patient samples and collaboration with key CROs and collaborators. Robyn has a deep understanding of HTA regulations and compliance with GCP and GLP.